Edition:
United States

Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

24.90USD
24 Feb 2017
Change (% chg)

$-0.10 (-0.40%)
Prev Close
$25.00
Open
$24.90
Day's High
$25.15
Day's Low
$24.35
Volume
416,167
Avg. Vol
677,590
52-wk High
$37.36
52-wk Low
$16.40

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.09 December 25 Feb 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 3 3 3 3
(3) HOLD 6 5 5 3
(4) UNDERPERFORM 0 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.60 2.60 2.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 9 127.07 132.40 120.53 --
Quarter Ending Jun-17 9 140.66 143.50 138.26 --
Year Ending Dec-17 9 568.68 577.00 561.01 561.63
Year Ending Dec-18 10 642.09 762.51 411.25 685.03
Earnings (per share)
Quarter Ending Mar-17 7 0.09 0.25 -0.05 --
Quarter Ending Jun-17 7 0.28 0.44 0.21 --
Year Ending Dec-17 7 1.13 1.49 0.80 0.94
Year Ending Dec-18 8 1.70 2.37 0.63 1.02

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-16 138.70 140.63 1.93 1.39
Quarter Ending Sep-16 134.01 135.61 1.61 1.20
Quarter Ending Jun-16 128.66 127.46 1.20 0.93
Quarter Ending Mar-16 115.36 115.90 0.54 0.47
Quarter Ending Sep-15 115.52 148.20 32.68 28.29
Earnings (per share)
Quarter Ending Dec-16 0.12 0.05 0.07 59.61
Quarter Ending Sep-16 0.11 -0.04 0.15 136.36
Quarter Ending Jun-16 0.20 0.07 0.13 64.70
Quarter Ending Mar-16 0.08 0.07 0.01 10.26
Quarter Ending Dec-15 0.22 0.28 0.06 24.83

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 127.07 127.07 127.97 126.21 --
Quarter Ending Jun-17 140.66 140.66 138.68 135.93 --
Year Ending Dec-17 568.68 561.07 555.82 547.75 561.63
Year Ending Dec-18 642.09 642.09 602.15 594.96 685.03
Earnings (per share)
Quarter Ending Mar-17 0.09 0.09 0.05 -0.10 --
Quarter Ending Jun-17 0.28 0.28 0.23 0.08 --
Year Ending Dec-17 1.13 1.03 1.06 0.77 0.94
Year Ending Dec-18 1.70 1.70 1.29 1.40 1.02

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 0 0 2 4
Quarter Ending Jun-17 0 0 3 2
Year Ending Dec-17 0 0 5 3
Year Ending Dec-18 0 0 4 0
Earnings
Quarter Ending Mar-17 0 0 2 3
Quarter Ending Jun-17 0 0 2 1
Year Ending Dec-17 0 0 3 2
Year Ending Dec-18 0 0 3 1

More From Around the Web